MSLE · Satellos Bioscience Inc. · Documents
Market Cap
$206.86M
Shares
21.22M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-09-09 | — | |
| 6-K | 2026-09-01 | — | |
| 6-K | 2026-08-14 | — | |
| 6-K | 2026-08-13 | 2026-06-30 | |
| 6-K | 2026-07-08 | — | |
| 6-K | 2026-06-29 | — | |
| 6-K | 2026-06-25 | — | |
| 6-K | 2026-06-18 | 2026-06-17 | |
| 6-K | 2026-06-17 | — | |
| Investor Event Transcript | 2026-06-02 | 2026-06-30 | |
| 6-K | 2026-05-27 | — | |
| 6-K | 2026-05-20 | 2026-05-19 | |
| 6-K | 2026-05-15 | 2026-03-31 | |
| Investor Event Transcript | 2026-04-21 | 2026-06-30 | |
| 6-K | 2026-04-09 | — | |
| 6-K | 2026-03-27 | — | |
| 40-F | 2026-03-27 | 2025-12-31 | |
| 6-K | 2026-03-10 | — | |
| 6-K | 2026-02-24 | — | |
| 6-K | 2026-02-19 | — | |
| 6-K | 2026-02-18 | — | |
| 6-K | 2026-02-17 | — | |
| 6-K | 2026-02-12 | 2026-02-10 | |
| 6-K | 2026-02-10 | 2026-02-09 | |
| 6-K | 2026-02-10 | — | |
| 6-K | 2026-02-06 | — |
Showing 1–26 of 26 filings
Key facts
CIK
1421642
CUSIP
80401L803
13F (30d)
20 filings
20 filers
Visit website
Investor relations